Micro-PET imaging and small animal models of disease
- 21 May 2003
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 15 (4) , 378-384
- https://doi.org/10.1016/s0952-7915(03)00066-9
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Monitoring Gene Therapy by Positron Emission TomographyPublished by Wiley ,2002
- Advances in In Vivo Bioluminescence Imaging of Gene ExpressionAnnual Review of Biomedical Engineering, 2002
- Bioluminescent indicators for in vivo measurements of gene expressionTrends in Biotechnology, 2002
- Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transductionGene Therapy, 2001
- Quantitative imaging of gene induction in living animalsGene Therapy, 2001
- Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectorsGene Therapy, 2001
- Approaches to gene therapy with sodium/iodide symporterExperimental and Clinical Endocrinology & Diabetes, 2001
- Synthesis of 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): A potential imaging agent of viral infection and gene therapy using PETNuclear Medicine and Biology, 1996
- 3-(2′-[18F]fluoroethyl)spiperone, a potent dopamine antagonist: Synthesis, structural analysis and in-vivo utilization in humansInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1990
- Preparation of 11C-labelled raclopride, a new potent dopamine receptor antagonist: Preliminary PET studies of cerebral dopamine receptors in the monkeyThe International Journal of Applied Radiation and Isotopes, 1985